AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Jan 30, 2013
30071_dirs_2013-01-30_e12da34c-c5c2-4fbe-af6c-7fdd1e4cc120.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-01-28
Reporting Person: WAREHAM JOHN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-28 | ResMed Common Stock | M | 36000 | $15.520 | Acquired | 49000 | Direct |
| 2013-01-28 | ResMed Common Stock | S | 36000 | $48.20 | Disposed | 13000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-28 | ResMed Common Stock Options | $15.520 | M | 36000 | Disposed | 2015-11-20 | ResMed Common Stock (36000) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29